Studies of the human microbiome are progressing rapidly but have largely focused on populations living in high‐income countries. With increasing evidence that the microbiome contributes to the pathogenesis of diseases that affect infants, children, and adults in low‐ and middle‐income countries (LMICs), and with profound and rapid ongoing changes occurring in our lifestyles and biosphere, understanding the origins of and developing microbiome‐directed therapeutics for treating a number of global health challenges requires the development of programs for studying human microbial ecology in LMICs. Here, we discuss how the establishment of long‐term human microbial observatory programs in selected LMICs could provide one timely approach.
No takes yet. Share an insight, caveat, or question.
Gordon et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: